SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-053925
Filing Date
2019-10-24
Accepted
2019-10-24 19:18:51
Documents
2
Period of Report
2019-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3337
2 EX-24 DOCUMENT attachment1.htm EX-24 3542
  Complete submission text file 0001209191-19-053925.txt   8226
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Kewalramani Reshma (Reporting) CIK: 0001735944 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 191167050